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Newneurons are continuously generated fromneural stemcellswith astrocyte properties, which reside in close proximity to the ventricle
in the postnatal and adult brain. In this study we found that microRNA-124 (miR-124) dictates postnatal neurogenesis in the mouse
subventricular zone. Using a transgenic reportermousewe show thatmiR-124 expression is initiated in the rapid amplifying progenitors
and remains expressed in the resulting neurons. When we stably inhibited miR-124 in vivo, neurogenesis was blocked, leading to the
appearance of ectopic cells with astrocyte characteristics in the olfactory bulb. Conversely, whenwe overexpressedmiR-124, neural stem
cells were not maintained in the subventricular zone and neurogenesis was lost. In summary, our results demonstrate that miR-124 is a
neuronal fate determinant in the subventricular zone.
Introduction
In the postnatal mammalian brain, neural stem cells (NSCs)
reside in the subventricular zone (SVZ) (Doetsch et al., 1999).
These cells generate new neurons that migrate via the rostral
migratory stream (RMS) to the olfactory bulb (OB). The
NSCs, often termed type B cells, are of astrocytic lineage ex-
pressing glial fibrillary acidic protein (GFAP) and have the
morphology and ultrastructural properties of astrocytes
(Doetsch et al., 1999; Laywell et al., 2000; Skogh et al., 2001;
Imura et al., 2003; Merkle et al., 2004). Type B astrocytes
undergo asymmetric cell division to generate rapid amplifying
progenitors (type C cells) that subsequently differentiate into
neurons. This cellular transformation is accompanied by tran-
scriptional changes for which the underlying molecular mech-
anisms remain largely unknown.
MicroRNAs (miRNAs) are small, noncoding, endogenous
RNA that bind to and regulate mRNA targets, making them
central players of gene regulation (Bartel, 2009). In neurons,
miR-124 is one of the most abundant miRNAs (Lagos-
Quintana et al., 2002). The expression of microRNA-124
(miR-124) is initiated upon neural differentiation and reaches
high levels in mature neurons (Cao et al., 2007; Makeyev et al.,
2007; Visvanathan et al., 2007; Cheng et al., 2009; Sanuki et al.,
2011). Several in vitro studies suggest that miR-124 plays a role
in neuronal fate determination. For example, delivery of miR-
124 duplexes to HeLa cells induces a neuronal gene profile
(Lim et al., 2005), and forced expression of miR-124 in pro-
genitor cells causes neuronal differentiation (Visvanathan et
al., 2007; Yu et al., 2008).
Nevertheless, despite the observed upregulation of miR-124
during NSC neuronal differentiation (Cheng et al., 2009), in vivo
blockade of this miRNA by antisense oligonucleotides only re-
sulted in subtle phenotypes, with mild delays in differentiation
and no detectable malformation (Cao et al., 2007; Visvanathan et
al., 2007; Cheng et al., 2009). Based on these findings, it was
concluded, that miR-124 regulates proliferation but does not af-
fect the glia/neuronal fate choice (Cheng et al., 2009). However,
these results were obtained using a technique, in vivo infusions of
antisense molecules, which only induced a transient inhibition.
In addition, targeting of specific cell types, such as type B astro-
cytes, could not be ascertained since the antisensemolecules were
not coupled to a reporter.
Here, to study the role of miR-124 in the postnatal SVZ, we
generated a transgenic reportermouse that allows visualization of
miR-124 activity in the brain in vivo. We demonstrate that in the
SVZ stem cell niche, miR-124 activity is initiated already in tran-
sient amplifying progenitors, type C cells, suggesting that it is not
linked to cell cycle exit. This findingwas substantiatedwith loss of
function studies of miR-124 in the SVZ, demonstrating that sta-
ble inhibition of this miRNA does not force progenitors to re-
main cycling. miR-124 loss of function, rather, blocks adult
neurogenesis and induces the formation of ectopic astrocytes in
the OB derived from the SVZ. Furthermore, when we overex-
pressed miR-124 in the SVZ, we found that NSCs lost their stem
cell characteristics, resulting in a loss of continuous supply of new
neurons to the OB.
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Materials andMethods
Viral vectors. The lentiviral vectors used in this study were third-
generation self-inactivating vectors. miRNA target sequences were
cloned into the 3 untranslated region (UTR) of the transgene expres-
sion cassette as follows: four tandem repeats of a target sequence
perfectly complementary to miR-124 (TTAAGGCACGCGGTGAAT
GCCA) were synthesized starting from the following 5 phosphory-
lated, SDS-PAGE purified DNA oligonucleotides: sense1: CTAGAT
AATGGCATTCACCGCGTGCCTTAATTCGAATGGCATTCACCGC
GTGCCTTAAACGCGT; sense2: TGGCATTCACCGCGTGCCTTAA
ATGCATTGGCATTCACCGCGTGCCTTAAC; antisense1: TTAAGG
CACGCGGTGAATGCCATTCGAATTAAGGCACGCGGTGAATGC
CATTAT; antisense2: CCGGGTTAAGGCACGCGGTGAATGCCAA
TGCATTTAAGGCACGCGGTGAATGCCAACGCGT. Sense1 and
antisense1, as well as sense2 and antisense2, were hybridized by slow
cooling from 95°C down to 37°C, respectively. The resulting double-
stranded DNA oligonucleotides could anneal to each other by an
ACGCGT sticky end, producing the 119 bp long fragment containing
four miR-124 targets with a 5 CTAG and a 3 GGCC overhang allow-
ing insertion into the XbaI-XmaI site, contained immediately down-
stream the woodchuck hepatitis virus posttranscriptional response
element (WPRE) of a third-generation lentiviral vector, expressing
green fluorescent protein (GFP) from the phosphoglycerate kinase
(PGK) promoter derived from the phosphoglycerol kinase house-
keeping gene. This promoter results in robust, ubiquitous, moderate-
level transgene expression, with very little tendency to transgene
silencing/variegation.
Similarly, eight tandem repeats of an imperfectly complementary se-
quence forming a central bulge when binding to miR-124 (hereafter
referred to as “sponge”) were synthesized and cloned into a third-
generation lentiviral vector containing a strong promoter derived from
cytomegalovirus (CMV), which drives overexpression of the miR-124
sponge, a requirement for successful miR-124 knockdown. ThemiR-124
sponge sequence is as follows: TTAAGGCACG-TA-TGAATGCCA. The
miR-125b sponge sequence is as follows: TCACAAGTTTAGTCT-
CAGGGA. A detailed description of how to design and use lentiviral
miRNA reporter and sponge vectors has been described previously
(Brown et al., 2007; Gentner et al., 2009).
A miR-124–1 overexpression vector (referred to as miR-124OE vec-
tor) was obtained by PCR amplification of a 484 bp (miR sequence 84 bp,
200 bp flanking on either side) genomic fragment from mouse DNA.
Primers were as follows: forward, ATGAATTCTCGCCAGCTTTTTCTT
TCTC; reverse, ATGAATTCATTTGCATCTGCACAAACCC. This frag-
ment was subsequently cloned between theGFP and theWPRE sequence
in pFUGW (Lois et al., 2002). The fragment encoding a human miR-
125bwas amplified from humanDNA. Primers were as follows: forward,
ATTCTAGAGTTGCGCTCCCCTCAGTC; reverse, ATGGTACCGCAG
CTCCCAAGAGCCTAAC. All cloning was performed using standard
techniques.
Lentiviral vectors were produced as previously described (Zufferey et
al., 1997). Lentiviral vectors were titrated using flow cytometry and
quantitative PCR analysis as previously described (Georgievska et al.,
2004). The titers of the vectors in this study were in the range of 2 
108 – 1 109 TU/ml.
To validate themiR-124OE-vector, 50,000HeLa cells were plated in 12
well plates. Two hours after plating, cells were transduced with volumes
of 0.3, 0.5, 1, 2, or 5 l of concentrated miR-124OE-vector. RNA was
extracted 72 h after transduction, followed by locked nucleic acid (LNA)
qRT-PCR. The titer of this vector batch was 2 108.
For the sponge validation experiments, HeLa cells were transduced at
amultiplicity of infection (MOI) of 10 for themiR-124 sponge vector and
an MOI of 5 for the miR-124OE vector. RNA was extracted 72 h after
transduction followed by qRT-PCR. Extraction of RNA, generation of
cDNA, and qRT-PCRwere performed as previously described (Sachdeva
et al., 2010). Primer sequences were as follows: Evovl1: forward, CCCC
GGGAGGAATGGGCTCTT, reverse, TAGGGTTGTGCCACAGGGCC
A; Jag1: forward, AGGCCACGTGCAACAACGGT, reverse, AGGGGT
TGGGCAGGCAGCTA. An unpaired t test was performed to test for
statistical significance. Data are presented as mean SEM.
Luciferase reporter assay. Sequences incorporating the putative
miR-124 binding sites of Jag1 3UTR were amplified from mouse
genomic DNA and cloned in the dual luciferase reporter vector
pSICHECK-2 (Promega). Primers were as follows: Jag1utr forward,
CTCGAGCGCTCTCACAGCTATGCAAAA; Jag1utr reverse, GCGG
CCGCTGGCTTACAGGCAACACGTTA. The luciferase reporter
construct was cotransfected with the lentiviral miR-124 overexpres-
sion construct and the miR-124 sponge construct into HeLa cells
using Turbofect (Fermentas). Forty-eight hours after transfection,
cells were assayed for Luciferase activity using a dual-luciferase assay
(Promega). An unpaired t test was performed to test for statistical
significance. Data are presented as mean  SEM.
Animals. All animal-related procedures were approved by and con-
ducted in accordance with the committee for the use of laboratory ani-
mals at Lund University and E´cole Polytechnique Fe´de´rale de Lausanne.
Lentiviral transgenesis was performed as previously described (Sau-
vain et al., 2008). Offspring were genotyped, and number of integrated
transgenes was estimated using quantitative real-time PCR. Primers were
as follows: WPRE: forward, GGCACTGACAATTCCGTGGT; reverse,
AGGGACGTAGCAGAAGGACG; probe WPRE: ACGTCCTTTCCATG
GCTGCTCGC; Titine forward, AAAACGAGCAGTGACGTGAGC; re-
verse, TTCAGTCATGCTGCTAGCGC; probe Titine: TCGACGGAAG
CGTCTCGTCTCAGTC. The data were quantified using the Ct-
method. The transgene data (WPRE primer) was normalized with the
Titine data to give the number of transgenes in the genome of each
animal.
For vector injections, 1l of concentrated lentiviral vector was unilat-
erally injected into the right ventricles of NMRImice at postnatal day (P)
3 (males and females; Charles River). The pups were placed on ice for 5
min before positioning them in an ice-cold stereotaxic frame. Coordi-
nates from bregma were as follows: AP 0.8, ML 0.8, DV 1.9. Mice
were perfused 1, 2, 3, 4, or 8 weeks postinjection. A proportion of the
animals were given an intraperitoneal pulse of 50 mg/kg BrdU (Sigma)
2 h before the 4 week time point. We used similar titers for all experi-
ments. We found similar results when analyzing either the ipsilateral or
the contralateral hemisphere after vector injection.
Immunofluorescence.Mice were transcardially perfused with 4% para-
formaldehyde (PFA) (Sigma), and the brains were postfixed for 2 h and
transferred to PBS with 25% sucrose. Brains were coronally sectioned on
amicrotome (35m) and put in potassium PBS. Embryonic brains were
fixed in 4% PFA overnight followed by PBS with 15% sucrose and sec-
tioned coronally on a cryostat (14 m).
Similar procedures was used for both fixed sections and cells, as
published in detail previously (Thompson et al., 2005; Sachdeva et al.,
2010). Primary antibodies were diluted as follows: chicken anti-GFP
1:1000 (Abcam), rabbit anti-GFAP 1:1000 (DAKO), goat anti-DCX
1:400 (Santa Cruz Biotechnology), mouse anti-NeuN 1:1000 (Milli-
pore), mouse anti-S100 1:500 (Sigma), rabbit anti-IBA1 1:1000
(Wako Chemicals), mouse anti-MASH1 1:200 (BD Biosciences),
mouse anti-O4 1:100 (Millipore), and rabbit anti-PERIPHERIN
1:200 (Covance). The dilution factor of the secondary antibodies was
1:500 (Invitrogen) or 1:200 (Jackson Laboratories).
For BrdU staining, the slices were fixed for 20min in 4%PFA followed
by incubation at 65°C in 1 M HCl before addition of the primary anti-
body (1:500 rat anti-BrdU; Serotec).
Quantification of GFP expressing cells in the OB. Three representative
OB sections (35 m) from each of three control injected, three sponge
injected, and three overexpressing injected animals were selected for
quantification. Fluorescent images of GFP expression were taken with
the same exposure, and all GFP-expressing cells of the sections were
counted. The OB was divided into different cell layers, including the
granule cell layer (GCL), mitral cell layer, internal plexiform layer, exter-
nal plexiform layer, and glomerular layer based on DAPI staining. An
unpaired t test was performed to test for statistical significance. Data are
presented as mean SEM.
Neurosphere cultures. Generation and culturing of embryonic day (E)
13.5 and adult neurospheres were performed as previously described
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with minor modifications (Ahlenius and Kokaia, 2010). In brief, half the
forebrain from eachmiR-124.T or GFP control E13.5 fetus was dissected
and placed in DMEM/F12 basic medium with trypsin and DNase. The
tissue was mechanically suspended by pipetting followed by incubation
in 37°C for 30 min. Cells were plated out in DMEM/F12 supplemented
with 20 ng/ml EGF and 10 ng/ml bFGF at a density of 100,000 cells/ml
and were cultured in a humidified incubator at 37°C with 5% CO2.
Neurosphere cultures were passaged using mechanical dissociation ap-
proximately every 7 d.
For adult neurospheres, 8 week old wt NMRI mice or 4.3 week old
NMRImice injectedwithCMV.1000 in the ventricle at P3were used. The
mice were lethally anesthetized, and each brain was removed from the
skull. The brain was put in ice-cold L15 media and transferred to a
coronal brain matrix, and 1 mm thick sections were cut. From those, the
SVZ region was dissected out under a dissection light microscope. SVZ
from four different animals was pooled in L15 medium. The tissue was
dissociated in HBSS with HEPES, glucose, trypsin, DNase, hyaluroni-
dase, and kynurenic acid in 37°C for 30 min, followed by titration by
pipetting. Adult neurospheres were cultured in Neurobasal basic me-
dium supplemented with EGF, bFGF, and heparin. Cultures were pas-
saged every 7 d using Accutase (Sigma) and mechanical dissociation.
FACS analysis of dissociated neurospheres was performed at passages
1–2, as previously described (Jonsson et al., 2009).
Fluorescence in situ hybridization. LNA-FISH was performed as previ-
ously described with minor modifications (Silahtaroglu, 2010). In brief,
fresh frozen brain tissue was cut at 14mon a cryostat on charged slides
and kept at20°C until use. Upon staining, slides were dried and fixed
with 4% PFA for 10 min. The slides were hybridized with a DIG-labeled
miR-124 LNA-probe (Exiqon) diluted 1:200 for 1 h at 67°C. Following
hybridization, slides were washed in 0.1 SSC at 75°C followed by treat-
Figure 1. miR-124 is a neuron-specificmiRNA.A, Illustration of the vectors and experimental approach to generatemiR-124.T reportermice using lentiviral transgenesis. Lentiviral vectors were
injected into the perivitelline space of fertilized embryos,whichwere transplanted into a pseudopregnantmouse.B, The vector-encoded transcript is expressed in bothmiR-124 expressing cells and
nonexpressing cells. In themiR-124-expressing cells, the target site containing transcripts is suppressed, resulting in no GFP expression. C–E, GFP expression inmiR-124.T reporter mice was found
exclusively in nonneuronal cells throughout thebrain. Controlmice (PGK.GFP) displayedGFP activity in all cells of the brain. Scale bars, 100m.F–H , Confocal analysis of GFP cells inmiR-124.Tmice
showing that neurons (NeuN) do not express GFP while astrocytes (GFAP) and microglia (IBA1) do. Scale bars, 10m. cPPT, Central polypurine tract; SIN, self-inactivating.
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ment with 3% H2O2. The slides were then incubated with an anti-DIG-
antibody (1:100; Roche) overnight and developed using Cy3-tyramide
(PerkinElmer) for 2 h. Slides were counterstained with DAPI and cover-
slippedwith polyvinyl alcoholmountingmediumwithDABCO (Sigma).
LNA-qRT-PCR. Total RNA, including miRNA, was extracted from
dissociated neurospheres using the miRNeasy kit (Qiagen) followed by
Universal cDNA synthesis kit (Exiqon). LNA–PCRprimer sets, hsa-miR-
124 and hsa-miR-103 (normalization miRNA), were purchased from
Exiqon and were used together with LightCycler 480 SYBR Green I Mas-
ter (Roche). Standard procedures of qRT-PCR were used, and data were
quantified using the Ct-method.
Results
Generation of miR-124 sensor transgenic mice
Studies of miRNA expression patterns in the brain in histological
preparations have up to now mostly relied on ISH techniques
(Pena et al., 2009). However, ISH requires high stringency, and it
is often incompatible with other labeling techniques such as im-
munohistochemistry. In addition, discriminating between the
pre-miRNA andmaturemiRNA is difficult through ISH,making
it complicated to detect potential posttranscriptional regulation,
which is thought to play a prominent role in controlling the
activity of miRNA (Obernosterer et al., 2006). To circumvent
these issues, we decided to generate a transgenic sensor mouse
that can report the activity of miR-124.
Lentiviral vectors expressing a reporter gene regulated by four
copies of a perfectly matched miRNA target sequence can be
exploited to monitor miRNA activity (Brown et al., 2007; Sach-
deva et al., 2010). For this study we used a lentiviral vector con-
taining a GFP reporter gene followed by four copies of perfect
matching miR-124-target sequences (miR-124.T) (Fig. 1A).
When miR-124 is present in the cell, it binds the miR target
sequence in the vector-derived mRNA and efficiently inhibits
GFP expression. In cells in which miR-124 is not expressed, the
mRNA remains active, and GFP expression from the ubiquitous
PGK promoter is easily detected (Fig. 1B). We used the miR-
124.T-vector to generate transgenic mice through lentiviral
transgenesis (Lois et al., 2002; Sauvain et al., 2008). High-
concentration lentiviral vectors were injected into the perivitell-
ine space of fertilized single-cell embryos followed by transfer to
surrogate mothers (Fig. 1A). We generated mice with either the
miR-124.T-containing or control GFP vectors (without miRNA
regulatory sites). Noteworthy, the simplicity and high efficiency
of lentiviral transgenesis allowed us to generate several founders
that each carried multiple copies of the transgenes. We then
analyzed offspring from six founders for each construct, all
carrying 5–15 copies of the vector, and found no difference in
GFP expression patterns among lines. Furthermore, we per-
formed intercrosses between founders that, in theory, further
reduce the risk for position-dependent effects, and when ana-
lyzing such animals we found the same expression pattern as
with F0 generation mice.
Figure 2. Characterization ofmiR.124.Tmice. A, Adult miR.124.Tmice display low GFP expression in the brain, while other tissues, here exemplified by lung and heart, display similar GFP levels
as control animals. B, The developing brain is almost entirely depleted of miR-124 activity at E13.5, as shown by diaminobenzidine-staining for GFP. Scale bar, 1 mm. C, Confocal analysis of E13.5
peripheral ganglion reveals GFP expression in peripheral nervous system neurons labeled with PERIPHERIN. Scale bars, 100m. D, Generation of neurospheres from forebrain of E.13.5 miR.124.T
embryos. FACSplots showing that inmiR.124.T cultures,20%of the cells expressGFPat early passages.E,F , FACS sortingof theGFP-expressing cells followedbyLNA-qRT-PCR formaturemiR-124
reveals thatmaturemiR-124 levels are higher in the GFP negative fraction.G, LNA-ISH for miR-124 reveals high-level expression in neurons (top). There is also an absence of miR-124 expression in
the ependymal layer that mirrors the expression pattern in miR-124.T mice (bottom). LV, lateral ventricle. Scale bars, 100m. Neg, Negative.
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miR-124 activity is detected in all neuronal populations in the
adult brain but not in glia
Histological examination of adult brains from miR-124.T mice
revealed that all neuronal populations throughout the anterior/
posterior axis lack GFP expression (exemplified in Fig. 1C–E by
low-magnification images fromhippocampus, striatum, and cer-
ebellum). Using double-labeled immunohistochemistry for GFP
and the neuronal marker NeuN, we found no evidence for GFP-
expressing neurons in any brain region examined (Fig. 1C–F). In
contrast, GFP control mice showed abundant GFP expression in
NeuN-positive cells (Fig. 1C–E). The GFP-expressing cells found
in the brains of themiR-124.Tmice had a nonneuronalmorphol-
ogy resembling different glial cell types. Colabeling with GFAP
and IBA1 confirmed that astrocytes andmicroglia do not display
miR-124 activity (Fig. 1G,H).
We analyzed grossly dissected organs from the miR-124.T
mice and found that the brain was mostly devoid of GFP expres-
sion when compared with control GFP mice (Fig. 2A). In other
organs such as lung and heart there was no major difference in
GFP expression (Fig. 2A). FACS analysis of white blood cells
from miR-124.T mice showed similar GFP expression levels as
GFP control mice (data not shown). In addition, we analyzed
GFP expression in embryos at E13.5 and found that miR.124.T
embryos displayed a lack of GFP expression exclusively in the
Figure3. miR-124activity is absent fromstemcells but initiated in rapid-amplifyingprogenitors in the adult SVZ.A, GFP/NeuNexpression in the adult SVZ inmiR-124 reportermicedemonstrates
thatmiR-124 is absent fromparts of theniche. Scale bars, 100m.B–D, Cells that express GFP, thus lackingmiR-124, colabelwith S100 andGFAPbut only rarely incorporate BrdU in the SVZ. Scale
bars, 20m.E,F , GFP-expressing cells donot colabelwithmarkers for rapid-amplifying progenitors (MASH1) andmigratingneuroblasts (DCX) inmiR-124 reportermice. Scale bars, 20m.G, BrdU
pulse chase experiment inwhich the thymidine analogwas injected 4weeks before killing of the animals demonstrates that slowly dividing cells in the SVZ express GFP inmiR-124.Tmice. Scale bars,
20m.H, GFP expression in neurosphere cultures derived from the adult SVZ revealing a small population of green cells in spheres. Scale bar, 100m. I, GFP-expressing cells in themiR-124.Tmice
express the miR-124 target JAG1. Scale bars, 20m. LV, Lateral ventricle; w, weeks.
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developing brain (Fig. 2B). We also used miR.124.T embryos to
show thatmiR-124 is not active in the peripheral nervous system,
as demonstrated by GFP expression in PERIPHERIN-expressing
ganglion (Fig. 2C). Together, these data provide evidence that
miR-124 is a CNS neuron-specific miRNA.
To validate that the miR-124.T mice actually report miR-124
activity, we first generated neurosphere cultures from the fore-
brains of E13.5 embryos. These neurosphere cultures displayed
high-level GFP expression only in a proportion of the cells, cor-
responding to approximately 20% of the total number of cells in
the sphere (Fig. 2D). We FACS sorted GFP-expressing and GFP-
negative cells from the neurospheres and performed LNA-qRT-
PCR for miR-124 levels on RNA extracted from the sorted
populations. As expected, we found miR-124 expression only in
theGFP-negative population (Fig. 2E). It is worth noting that the
levels of miR-124 in the GFP-negative population of neuro-
spheres were approximately 60-fold lower than in adult mouse
brain tissue, suggesting that the miR-124.T-reporter system is
very sensitive (Fig. 2F).
We compared the GFP staining of miR-124.T mice with
fluorescent LNA-ISH for miR-124. miR-124-LNA-ISH results
in a high signal that appears to be present primarily in neu-
rons, thus supporting that the miR-124 reporter mice display
an inverse picture of miR-124 activity (Fig. 2G). However,
with LNA-ISH it was difficult to determine whether cell pop-
ulations expressing lower levels of miR-124 exist. A faint miR-
124 signal appeared in the SVZ that could correspond to
progenitors (Fig. 2F). Careful phenotypic identification of
cells in the SVZ was again impossible due to technical difficul-
ties in performing colabeling for several markers, including,
for example, BrdU-staining (data not shown).
With this in mind, lentiviral reporter mice expressing GFP
incorporatingmiRNA target sites provide a valuable tool tomon-
itor miRNA activity in the brain.
miR-124 activity is initiated in neurogenic niches in the
adult brain
We then focused our analysis on the SVZ stem cell niche in the
adult brain. In the SVZ, we detected GFP-expressing cells (i.e.,
not expressingmiR-124) lining the lateral ventricle (Fig. 3A), and
colabeling with S100 confirmed that ependymal cells express
GFP, thus not exhibiting miR-124 activity (Fig. 3B). To detect
proliferating cells, we injected BrdU 2 h before killing the mice.
Only rare GFP/BrdU-positive cells could be found, whichwere in
close contact with the ventricular wall, while the majority (esti-
mated to be 95%) of BrdU-positive cells did not express GFP
(Fig. 3C). BrdU primarily labels the rapid amplifying progenitors
type C, while only a small proportion of BrdU-labeled cells are
type B.
This conceptwas further confirmed by the finding thatGFAP-
expressing cells in the SVZ coexpressed GFP while bothMASH1-
expressing cells, which identifies type C cells, and doublecortin
(DCX)-expressing cells, which correspond to early migrating
neuroblasts, type A cells, were GFP negative (Fig. 3D–F). More-
over, we performed a pulse-chase experiment in which BrdUwas
injected 4 weeks before the animals were sacrificed. In these ani-
mals we found that themajority of the rare remaining BrdU-cells
in the SVZ, corresponding mostly to slowly proliferating stem
cell-like cells, were GFP positive (Fig. 3G). In contrast, the BrdU-
positive cells in the OB that correspond to adult generated neurons
were GFP negative (data not shown). We also derived neurosphere
cultures fromtheadult SVZofmiR-124.Tmice.Theseneurospheres
had a spotty appearance, with GFP-expressing cells intermingled
with non-GFP-expressing cells (Fig. 3H). One percent to 2% of the
neurosphere in early passage culture consisted of GFP-expressing
cells, resembling the number of expected self-renewing cells in
neurosphere cultures (data not shown). Finally, we investigated
the expression pattern of JAGGED1 (JAG1), which is a target
gene of miR-124 (Cheng et al., 2009; Liu et al., 2011). In our
miR-124 reporter mice, we detected JAG1 expression in cells lin-
ing the ventricle and in the SVZ. These cells colabeled with GFP,
confirming that miR-124 activity and JAG1 expression do not
overlap, providing in vivo evidence of miR-124 suppression of
Jag1 in the SVZ niche (Fig. 3I).
Whenwe analyzedmiR-124 activity in the dentate gyrus (DG)
of the hippocampus, which is the second neurogenic niche in the
adult brain, we found that GFP-expressing cells had an elaborate
morphology with a prominent radial process resembling what
has previously been described for neural progenitor cells in the
DG. A proportion of BrdU cells were GFP positive, while neuro-
blasts expressing DCX did not express GFP. This suggests also
that in the DG, miR-124 activity is rapidly initiated once the cell
exits the self-renewing state (Fig. 4A,B).
Together, these findings demonstrate that miR-124 activity is
absent from the actual NSC populations in the adult brain but is
initiated as soon as the cell is determined to become a neuron. An
interesting aspect is that in the SVZ this corresponds to type C
cells that rapidly undergo several cell cycles. Thus, miR-124 ini-
tiation does not correlate with cell cycle exit.
Figure 4. GFP expression in hippocampus in adult brain. A, In the DG we found GFP-
expressing cells with morphologies resembling what have previously been attributed to pro-
genitor cells. Confocal analysis revealed that a proportion of the GFP-expressing cells
incorporated BrdU. It is worth noting that the proportion of BrdU-incorporating cells that ex-
pressedGFPwashigher in theDGwhen comparedwith the SVZ,which reflects differences in the
proliferation of progenitors in the two niches.B, GFP-expressing cells did not colabel with DCX.
Scale bars, 20m.
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Inhibition of miR-124 activity impairs neurogenesis
Having found that miR-124 is absent from the GFAP-expressing
and BrdU-label retaining stem cells but is upregulated in rapid
amplifying progenitors, we hypothesized that miR-124 plays a
critical role in fate determination during SVZ neurogenesis. We
investigated this by stably inhibitingmiR-124 in the SVZ stemcell
niche using a lentiviral sponge strategy.
To achieve efficient targeting of the SVZ niche, including all
relevant cell types, we injected lentiviral vectors into the lateral
ventricles of mice at P3. At this time point, the ependymal layer is
not fully developed and the vector can therefore efficiently trans-
duce all cell types in the niche. Using a control CMV.GFP vector,
without miRNA sponge sequences, we found that injection of
lentiviral vectors into the lateral ventricles of P3 mice allows effi-
cient targeting of the SVZ stem cell niche. At 1 week postinjec-
tion, cells lining the ventricle expressed a high level of GFP (Fig.
5A). At 4 and 8 weeks after injection, we found that there were still
numerousGFP-expressing cells in the ventricular zone, and colabel-
ing demonstrated that ependymal cells (s100) and astrocyte-like
cells (GFAP) were expressing GFP (Fig. 5B–D). Eight weeks after
vector injection, there were GFP-expressing cells in the RMS coex-
pressing DCX, demonstrating a continuous supply of cells from the
SVZ (Fig. 5E). In the OB there was an increasing number of GFP-
expressing interneurons that with time colabeled with NeuN (Fig.
5F). To further confirm stable genetic modification of SVZ stem
cells, we performed a pulse chase experiment inwhich animals were
injectedwith BrdU4weeks after vector injection and then sacrificed
4 weeks later, at 8 weeks of age. GFP-expressing neurons in the OB
colabeled with BrdU (Fig. 5G), and to estimate the proportion of
transduced type B cells, we calculated the number of GFP/BrdU-
expressing cells in the OB to be 21  6% (n 	 4). Together, this
demonstrates that injection of lentiviral vectors into the lateral ven-
tricle of P3mice allows efficient targeting of the SVZ stem cell niche,
including the slowly dividing GFAP-expressing type B stem cells.
To inhibitmiR-124we used a lentiviral sponge vector express-
ing eight copies of an imperfect miR-124 target sequence driven
by a strong CMV promoter (Fig. 6A), a design that has been
optimized to inhibit miRNA activity in vivo (Gentner et al.,
2009). The vector contains a GFP reporter gene that is only de-
tectably expressed when miR-124 is inhibited or in cells lacking
miR-124, allowing for simple detection of sponged cells (Gentner
et al., 2009). We validated the functionality of the miR-124
sponge construct by demonstrating its ability to de-repress
transcripts controlled by miR-124 using a luciferase reporter
assay as well as by performing qRT-PCR for endogenous target
genes (Fig. 6B,C). When we inhibited miR-124 expression in
the SVZ using miR-124 sponge vectors, we found that trans-
duced GFP sponge-expressing cells displayed reducedOB neuro-
genesis 4 weeks after vector injection (n 	 7). In the OB there
were very few GFP sponge-expressing neurons when compared
with CMV.GFP-injected animals, and all these neurons ex-
pressed a low level of GFP (Fig. 6D,E). These lowGFP-expressing
neurons most likely correspond to cells in which the sponge is
expressed at low levels due to low copy number, resulting in
insufficient miRNA inhibition. However, even after amplifica-
tion of the GFP signal using immunohistochemistry, these cells
corresponded to
10%ofGFP cells when comparedwith control
inject animals. In the SVZ we found numerous GFP-expressing
cells lining the ventricle (Fig. 6F). In the RMS we could not find
any DCX-GFP-expressing cells (Fig. 6G). Careful examination of
transduced cells in the SVZ and RMS revealed that they were
expressing either S100 or GFAP but never DCX (Fig. 6H, I).
When we pulsed with BrdU 2 h before sacrifice, we only detected
very few GFP-expressing cells that were BrdU positive in the SVZ
Figure 5. Injection of lentiviral vectors into the ventricles of p3 mice allows efficient targeting of SVZ stem cells. A, B, We found abundant GFP expression in the ventricular zone at both 1 week
and 8weeks after vector injection. Scale bars, 100m. C,D, Eight weeks after injectionwe found GFP-expressing cells colabelingwith either GFAP or S100 in the SVZ. Scale bars, 50m. E, In the
RMSwe found GFP-expressingmigrating neuroblasts (DCX) 8 weeks after vector injection demonstrating an ongoingmigration of GFP-expressing progenitors. Scale bars, 100m. F, In the OBwe
found numerous GFP-expressing neurons that colabeledwith the neuronalmarker NeuN 8weeks after vector injection. Scale bars, 100m.G,We also performed a pulse chase experiment inwhich
animals were injected with BrdU 4 weeks after vector injection and then killed 4 weeks later, at 8 weeks of age. We found GFP-expressing neurons in the OB that colabeled with BrdU. This
demonstrates that cells dividing 4 weeks after vector injection still retain the GFP transgene, showing that slowly dividing stem cells are targeted. Scale bar, 10m. w, Weeks.
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(estimated to be
1%; Fig. 5J). These data suggest that miR-124
inhibition affects the transition from type B stem cells into rapid
amplifying progenitors, type C cells, and subsequent neuronal
differentiation. It is worth noting that ependymal cells (not ex-
pressing miR-124) expressed high levels of the sponge (GFP) at
all time points investigated (1, 4, and 8 weeks) and displayed a
normal phenotype throughout, indicating that there is no toxic-
ity associated with the miR-124 sponge per se.
Interestingly, we found GFP-expressing cells in the RMS with
a glial-like morphology that colabeled with S100 4 weeks after
miR-124 sponge injection (Fig. 6K). Adding to this, we detected
cells with an astrocyte-like morphology in the OB expressing
GFP. These cells colabeled with both GFAP and S100 (Fig.
6L,M). The number of GFP-expressing astrocytes corresponded
to10 cells/section and could be found in all cell layers of theOB
(Fig. 6F). In animals injected with the CMV.GFP vector or a
sponge vector targeting the unrelated miR-125b, we never de-
tected GFP/S100- or GFP/GFAP-expressing cells in the RMS or
the OB (Fig. 6D,E,N).
Together, these results show that miR-124 inhibition reduces
neurogenesis and increases gliogenesis, leading to the formation
of ectopic glial cells in the OB. This demonstrates that miR-124
plays a critical role in regulating the molecular machinery that
governs the cellular transformation from an SVZ astrocyte-like
stem cell into an OB neuron.
Overexpression of miR-124 in the SVZ leads to loss of
self-renewing NSCs
Since miR-124 regulates postnatal neurogenesis, we furthermore
decided to investigate the consequence of miR-124 overexpres-
Figure 6. Stable inhibition of miR-124 in the SVZ blocks neurogenesis, leading to the formation of ectopic glial cells in the OB. A, Illustration of the vectors and experimental approach to inhibit
miR-124 in the postnatal SVZ. Lentiviral sponge vectorswere injected at P3. Illustration shows themigratory route of neuroblasts from the SVZ via the RMS to the OB.B, Luciferase assay in HeLa cells
for the miR-124 target gene Jag1 demonstrating the efficiency of the lentiviral constructs. Graph display ratio of Renilla to firefly luciferase activity normalized to cells transfected with the
Jag1–3UTR construct only. Data represent a mean of four independent experiments. Data are presented as mean SEM. *p
 0.05, Student’s t test. C, Examples of two miR-124 target genes
(Evovl1 and Jag1) that display reduced expression in HeLa cells followingmiR-124 overexpression (black bars). Coexpression of miR-124 sponge rescues the downregulation. Data are presented as
mean SEM; n	 6. *p
 0.05, Student’s t test. Evovl1 is taken from Conaco et al. (2006) and Jag1 from Cheng et al. (2009). D, GFP expression in the OB 4 weeks after control and sponge vector
injection. In animals injected with miR-124 sponge vectors, only very few GFP-expressing cells can be detected. OB is counterstained with DAPI. Scale bars, 250 m. E, Quantification of
GFP-expressing neurons and astrocytes in the OB after amplification of the GFP signal using immunohistochemistry. Data are presented as mean SEM; n	 3. ***p
 0.001. n.d., not detected.
F,G, GFP expression in the SVZ and RMS 4weeks after vector injection. SVZ is counterstainedwith s100 and the RMSwith DCX. Scale bars: 50m (F ); 75m (G).H–J, GFP-expressing cells in the
SVZ 4 weeks after injection of ctrl or miR-124 sponge vector. In animals injected with sponge vector, it was possible to detect GFP cells expressing s100 and GFAP, but these GFP cells did not
incorporate BrdU. BrdU was injected 2 h before kill. Scale bars, 10m. K, GFP-expressing cells in the RMS 4 weeks after injection of sponge vector colabeled with s100. Scale bars, 10m. L,M,
GFP-expressing cells in the OB 4weeks after sponge injection colabeledwith S100 and GFAP. Scale bars, 10m.N, GFP-expressing neurons in the OB 4weeks after injection of a control lentiviral
vector expressing a miR-125b sponge sequence. Scale bars, 100m. cPPT, Central polypurine tract; SIN, self-inactivating; w, weeks.
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sion in the SVZniche. To this end,we generated a lentiviral vector
containing a 484 bp genomic fragment containing miR-124–1
(miR-124OE) that allowed high-level expression of mature miR-
124 and a GFP marker (Fig. 7A).
When overexpressing miR-124 in the SVZ, we were unable to
detect GFP-expressing cells in the SVZ or the RMS 4 weeks after
delivery of the miR-124 overexpression vector although we did
detect GFP-neurons in the OB (n	 3; Fig. 7B–D). When using a
control GFP vector, we detected high-level GFP expression in the
SVZ, RMS, andOB (Fig. 7B–D). These data suggest thatmiR-124
overexpression is not compatible with the maintenance of type B
stem cells, leading to a loss of continuous supply of new neurons
to the OB via the RMS. To investigate this phenomenon in detail,
we killedmice 1, 2, and 3weeks aftermiR-124OE vector injection
(n 	 9). At 1 week postinjection, miR-124 overexpressing GFP
cells were found in the SVZ and the RMS, and we also found cells
with immature morphology that had entered the OB (Fig. 7E)
(data not shown). Starting at 2 weeks and evenmore so at 3 weeks
postinjection, there was a gradual loss of GFP-expressing cells in
the SVZ and in the RMS (Fig. 7F,G). These data suggest that
overexpression of miR-124 results in only a single wave of
GFP-expressing cells reaching the OB, which is in contrast to
the constant supply of new GFP neurons when using control
vectors. In control experiments, in which we used a lentiviral
vector with a similar design overexpressing the unrelatedmiR-
125b, we found GFP-expressing cells in the SVZ, RMS, and OB
4 weeks postinjection demonstrating a continuous supply of
new neurons (Fig. 7H ).
The number of GFP-expressing neurons detected in the OB 4
weeks aftermiR-124OE injectionwere fewer and arranged differ-
ently when compared with control injected animals (Fig. 7D, I–
K). When we analyzed the distribution of GFP cells in the
different cell layers in theOB,we found thatmiR-124 overexpres-
sion led to an increased integration into the GCL, with fewer cells
integrating into the glomerular layer compared with the control
GFP cells (Fig. 7J). Furthermore, the miR-124-overexpressing
cells were primarily found in the inner parts of theGCL (Fig. 7K).
This indicates that the level of miR-124 expression is important
for the timing of integration of newborn neurons and that forced
expression of miR-124 leads to premature differentiation once
the cell reaches the OB.
In summary, these data suggest that overexpression of miR-
124 in NSCs leads to loss of cells with stem cell characteristics
while it does not impairmigration of progenitors from the SVZ to
Figure7. OverexpressionofmiR-124 in thepostnatal SVZ leads to loss of neural stemcells.A, Illustrationof the vector to overexpressmiR-124 in thepostnatal SVZ. Lentiviral vectorswere injected
at P3. B, C, Four weeks after the injection of miR-124OE, no GFP-expressing cells can be detected in either SVZ or RMS, suggesting that all stem and progenitor cells overexpressing miR-124 have
migrated away and differentiated to OB neurons. D, In animals injected with miR-124OE vectors, OB neurons are generated to a lesser extent when compared with control injections. E–G,
GFP-expressing cells are gradually lost from the SVZ andRMSafter injection ofmiR-124OE vector.H, Injection of a control lentiviral vector overexpressing the unrelatedmiR-125b does not cause loss
of GFP expression in the SVZ andRMS. I, Quantification of GFP-expressing neurons in theOB. Data are presented asmean SEM; n	 3. **p
 0.01. J, Altered integration into theOB aftermiR-124
overexpression. Data are presented as mean SEM; n	 3. *p
 0.05. K, Newborn neurons overexpressing miR-124 integrate primarily in the inner parts of the GCL. LV, Lateral ventricle; M-OB,
most medial part of the OB. All scale bars, 100 m. cPPT, Central polypurine tract; EPL, external plexiform layer; GL, glomerular layer; IPL internal plexiform layer; MCL, mitral cell layer; SIN,
self-inactivating; UbiC, ubiquitin C; w, weeks.
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the OB. In addition, the precise level of miR-124 expression ap-
pears to regulate neuronal integration into the OB. Noteworthy,
we only detected very few GFP-expressing ependymal cells after
miR-124 overexpression. This suggests that ependymal cells
overexpressing miR-124 either are lost due to cell death or also
enter the migratory path to the OB to form interneurons.
Discussion
In this study we show that miR-124 is expressed and active in all
neuronal populations of the adult brain. We also demonstrate
that miR-124 activity is rapidly initiated once NSCs, type B cells,
transit to rapid-amplifying progenitors, type C cells. When the
upregulation of miR-124 expression is blocked, type C cells are
not generated, leading to a subsequent inhibition of neurogen-
esis. On the other hand, if miR-124 expression is forced in type B
cells they lose their stem cell characteristics.
Our strategy to detect miR-124 activity relies on the genera-
tion of a GFP reporter transgenic mouse. The detection of GFP
expression only in glial cell types, including astrocytes andmicro-
glia, demonstrates that miR-124 is active only in neurons and
cells destined to become neurons. This is in contrast to a recent
study in which miR-124 was reported to be expressed in resting
microglia (Ponomarev et al., 2011). This discrepancy is most
likely explained by the ability of the reporter mouse to detect the
activity of miR-124 at single cell resolution whereas the study by
Ponomarev et al. (2011) solely relies on PCR-based techniques
that are limited to measure expression levels. The possibility that
we would detect GFP expression in cells that are also displaying
miRNA activity is very unlikely. A false signal could be potentially
caused by loss of the miR.T sequence, but this would occur in a
random fashion and not specifically in astrocytes and oligoden-
drocytes, and the fact that we see similar expression patterns in
different founder mice further rules out this possibility. Alterna-
tively, a false signal could be caused by a lack of sensitivity of the
miRNA reporter system in detecting low levels of miRNA. Still,
such a low level of miRNA expression is most likely not relevant
for endogenous miRNA targets either (Brown et al., 2007;
Mukherji et al., 2011).
We found the reporter mouse particular useful when analyzing
neurogenesis since it allows for straightforward colabeling with rel-
evantmarkers such asBrdU,whichotherwisewouldbe complicated
to combine with standard miRNA detection techniques such as
LNA-ISH. The GFP reporter also permits morphological analysis,
which is not possible when using ISH-staining to detect miRNA. In
future studies, the miR.124.T mice generated here could be used in
studies to monitor changes in miR-124 levels in models of stroke,
neurodegenerative disorders, and brain cancer. Additionally, the
simplicityof lentiviral transgenesis shouldallowfor thegenerationof
a large number of this type of miRNA reporter mice, which would
greatly enhanceourunderstandingofmiRNAexpressionpatterns in
the brain.
Our loss-of-function and gain-of-function experiments sug-
gest that miR-124 is an essential part of the neuronal network.
This is in agreement with previous studies in which it has been
shown that overexpression of miR-124 in HeLa cells induces a
broad neuronal gene profile (Lim et al., 2005). Furthermore, two
recent reports demonstrate that overexpression of miR-124 con-
tributes to direct conversion of fibroblasts into functional neu-
rons (Ambasudhan et al., 2011; Yoo et al., 2011). Together, these
studies and ours indicate that miR-124 is a factor necessary for
the induction of the neuronal gene program. However, our re-
sults contrast, to some extent, a previous study by Cheng et al.
(2009)in which the authors concluded that miR-124 does not
influence neuron/glia fate decisions in the SVZ. The difference
between the studies lies primarily in our lentiviral strategy, which
leads to stable targeting of the type B stem cells, whereas Cheng et
al. (2009) used infusions of 2OMe-RNA antisense molecules
that are limited to a transient, nontargeted inhibition ofmiR-124
most likely occurring primarily in rapid-amplifying progenitors.
An interesting observation in our study is that at least a pro-
portion of the cells in which miR-124 was inhibited continued to
migrate to the OB without obtaining neuronal characteristics.
These data suggest that intracellular gene programs other than
those inducing a neuronal fate governs migration to the OB.
Our data show that ectopic expression of miR-124 in the SVZ
is not compatible with continuous neurogenesis. Rather, we ob-
served a single wave of neurogenesis when miR-124 was overex-
pressed. This “washout” of GFP-expressing cells follows a similar
temporal profile to what has been observed when injecting MLV
retroviral vectors into the ventricles of newborn rodents (Roge-
lius et al., 2005). MLV vectors target primarily the rapidly prolif-
erating type A and type C cells, suggesting that overexpression of
miR-124 in type B cells caused forced differentiation into neural
progenitors without self-renewing capacities. Alternatively, it is
possible that the loss of self-renewingGFP cells aftermiR-124 is at
least partly due to cell death. We have analyzed our material for
cell death markers but have not been able to detect dying cells
(data not shown). However, during the first postnatal weeks the
SVZ is a dynamic and expanding region, and cell death in re-
sponse to the overexpression may not be detectable. Still, the
presence of GFP-expressing cells in the SVZ, RMS, and OB at
different time points after the injection of miR-124OE demon-
strates that miR-124 overexpression does not always cause cell
death. Furthermore, our observations after miR-124 overexpres-
sion are in line with in vitro experiments in which miR-124 has
been overexpressed in cultured cells with neural progenitor char-
acteristics (Makeyev et al., 2007; Silber et al., 2008; Cheng et al.,
2009; Liu et al., 2011). In these studies, overexpression of miR-
124 led to reduced proliferation associated with forced neuronal
differentiation. These studies and our findings indicate thatmiR-
124 may in part act by the downregulation of genes that are
associated with stemness.
Of particular interest is the identification of the Notch-ligand
receptor JAG1 as a miR-124 target (Cheng et al., 2009; Liu et al.,
2011). Recent studies demonstrate a critical role for the Notch
pathway not only in regulating NSCs, but also in maintaining
ependymal cells in a nonproliferating state (Carlen et al., 2009).
The consequences ofmiR-124 overexpression in the SVZ are very
similar to Notch inhibition, suggesting that miR-124 is a crucial
player in this network. However, the molecular machinery con-
trolled by miR-124 appears to be complex; an mRNA target pre-
diction algorithm suggests1000 potential targets, and several of
those have been experimentally validated (targetscan.org). In the
adult SVZ,miR-124 has, in addition to JAG1, been demonstrated
to regulate SOX9, which is a transcription factor that controls
adult neurogenesis, as well as DLX2, a transcription factor medi-
ating neuronal subtype specification (Cheng et al., 2009). In light
of this, it will be interesting to identify the complete set of miR-
124 targets in neural progenitor cells. Recent studies demonstrate
that a combination of computational approaches, loss-of-
function experiments, and experimental determination of either
mRNA-Ago2 complexes (PAR-CLIP) ormiRNA-mRNA interac-
tion is necessary to obtain a reliable list of true miRNA targets
(Lal et al., 2011; Lipchina et al., 2011). The application of such
approaches to a small cell population in vivo is challenging but
will be a focus in our future work.
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